Analyst: Darzalex sales could reach top end of projections
Janssen’s recently published sales figures for cancer drug Darzalex indicate a promising year-end result is in store, according to a Sydbank analyst.
by marketwire, translated by daniel pedersen
On Tuesday, Genmab saw a bad stock market start turn around after its partner, US-based pharmaceutical firm Johnson & Johnson, released its first quarter figures for 2022, which revealed a sales advancement for bone marrow cancer drug Darzalex.
Expres2ion CEO Bent U. Frandsen is one of 3,000 volunteers participating in a phase III trial of Bavarian Nordic’s Covid-19 booster candidate. If the vaccine reaches the market, Expres2ion will be entitled to royalties.